Targeting YTHDF2 significantly suppresses tumor growth and progression by downregulating MCM2 and MCM5. These findings provide a link between protein O-GlcNAcylation and m6A-dependent mRNA regulation in HBV-associated HCC tumorigenesis (Fig. 8). Here, MCM5 is linked to neoplasm.